News

Australians consumed 34 per cent more methylamphetamine (meth), cocaine, heroin and MDMA in 2024 compared to 2023, according ...
The FDA has approved Ketarx, a ketamine-based drug developed by drugmaker PharmaTher, for use in pain management. The medication is now cleared by the FDA for clinical use in perioperative settings, ...
As the dust settles on its successful takeover of Awakn Life Sciences, investors are starting to appreciate the potential of ...
"Third time lucky as PharmaTher gets FDA approval for ketamine" was originally created and published by Pharmaceutical ...
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical ...